GSK to buy Boston-based IDRx for $1.15 billion GSK to buy Boston-based IDRx for $1.15 billion Post ContentgskRead More You might also be interested in reading BNB Chain Q3 Revenue Takes A Hit: Fees Plummet By 40%. January 13, 2025 In Mainstream ← Previous post Next post →